QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Plandaí Biotechnology, Inc. (PLPL) Initiates Clinical Trials For Phytofare Topical Product 0 comments
    Sep 8, 2013 12:03 AM | about stocks: PLPL

    Plandaí Biotechnology, developer of bioavailable plant extracts used in the health, wellness, nutraceutical, and pharmaceutical industries, reports that North-West University, a leading medical research facility in Potchefstroom, South Africa, will conduct several clinical studies involving the Phytofare™ Pheroid™ Topical Catechin Complex ("ph2TM"), a new topical cream based on the nano-entrapment technology developed by NWU professor Anne Grobler.

    The first of two studies, initiated last month, is testing the moisturizing effects of ph2TM on 35 human volunteers. A second study, also commenced last month on 35 human subjects, is testing the anti-inflammatory benefits of the product. A third human study slated to start later in the year will explore the anti-aging properties of the topical cream.

    ph2TM was recently licensed to PLPL for human and animal use and is expected to be marketed as an ingredient in a variety of skin care products.

    "We are enthusiastic about the potential for ph2TM Topical Catechin Complex in the nutriceutical market space," Roger Duffield, chairman and CEO of PLPL stated in the press release. "We've fielded multiple inquiries from large skin care product manufacturers interested in seeing the known benefits of green tea catechins transferred into a topical solution that can penetrate through the various tissue levels and be absorbed at the cellular level. We envision this product being incorporated into products ranging from skin rejuvenation to anti-aging to after shave."

    The studies for the new topical cream are expected to take roughly three months leading up to anticipated market release during the first quarter of 2014.

    For more information, visit plandaibiotech.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: PLPL
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.